The election of Republican Scott Brown to a U.S. Senate seat in Massachusetts Tuesday could give a short-term lift to the big-name medical device manufacturers at the top of the iShares Dow Jones US Medical Devices ETF (IHI) roster.
Top medical device firms like Medtronic (MDT), Thermo Fisher Scientific (TMO) and Stryker (SYK) have been under pressure during this young presidency as a major overhaul of the health care industry took shape.
As health care reform, once hallmarked by a government-backed public option, was increasingly slowed by the legislative process and mercurial public opinion, health care stocks rebounded.
Subsector ETF offer investors the unique ability to compare and track narrow slices of the market. While many ETFs currently compete in the health care space, a quick analysis of the iShares line-up offers a revealing look into this sector's trends.The iShares Dow Jones US Medical Devices ETF (IHI), iShares Dow Jones US Pharmaceuticals ETF (IHE) and iShares Dow Jones US Healthcare Providers ETF (IHF) all fell significantly in 2008 as President Obama's election loomed large and rebounded in 2009 as a massive health care overhaul seemed increasingly improbable. In 2008, IHI, IHE and IHF fell 36.79%, 14.91% and 43.46%, respectively. As a "public option" became less of a threat to health care providers in 2009, IHF rebounded more than 35%. IHI and IHE also improved 38.49% and 30.06% in 2009, respectively. Year to date, the controversy surrounding health care reform appears to have strengthened the stocks of top industry names. IHI, IHE and IHF are up 3.49%, 2.53% and 5.76% year to date respectively. While once-embattled health care providers like UnitedHealth Group (UNH) and WellPoint (WLP) are leading the pack, the companies that comprise IHI's portfolio could also get a jolt from the latest slow-down in health care reform.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV